| Income Statement |
| Operating Expenses | 2.74M |
|
| Research and Development Expense | 1.46M |
| Selling, General and Administrative Expense | 1.28M |
| Operating Income | -2.74M |
| Net Income | -2.67M |
| Net Income Common Stock | -2.67M |
| Net Income Common Stock (USD) | -2.67M |
| Consolidated Income | -2.67M |
| Earnings per Basic Share | 2.30 |
| Earnings per Basic Share (USD) | 2.30 |
| Earnings per Diluted Share | 2.30 |
| Earning Before Interest & Taxes (EBIT) | -2.67M |
| Earning Before Interest & Taxes (USD) | -2.67M |
| Weighted Average Shares | 343.66K |
| Weighted Average Shares Diluted | 343.66K |
| Balance Sheet |
| Cash and Equivalents | 7.00M |
| Cash and Equivalents (USD) | 7.00M |
| Current Assets | 7.58M |
| Property, Plant & Equipment Net | 19.00K |
| Total Assets | 7.60M |
| Current Liabilities | 1.71M |
| Total Liabilities | 1.71M |
| Accumulated Retained Earnings (Deficit) | -67.09M |
| Shareholders Equity | 5.90M |
| Shareholders Equity (USD) | 5.90M |
| Assets Non-Current | 19.00K |
| Trade and Non-Trade Payables | 700.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 3.00K |
| Net Cash Flow from Financing | -35.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.93M |
| Capital Expenditure | -3.00K |
| Issuance (Purchase) of Equity Shares | 5.00K |
| Net Cash Flow from Investing | -3.00K |
| Net Cash Flow from Operations | -2.89M |
| Share Based Compensation | 1000 |